What pharmacists need to know about new prescribing pilots

On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.

Could this medicine revolutionise schizophrenia treatment?

Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.

Oxybutynin for hot flashes when hormones can’t be used

Can oxybutynin be useful for some patients who are unsuited for hormonal pharmacotherapy? Some people might describe hot flashes as an unannounced and brief...

Treatment of acute pain with Pharmacist Only (S3) celecoxib

Effectively managing acute pain is a crucial aspect of patient care. This article explores current Pharmacist Only options for pain management following the recent market entry of Pharmacist Only celecoxib.

Intranasal naloxone spray could reduce opioid-related deaths

Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...

Content unavailable

Sorry, this content is only available to users that the PSA have verified as healthcare professionals. To learn more, talk to a PSA membership...